Drug profile · INN
amodiaquine hydrochloride
CAMOQUIN HYDROCHLORIDE
amodiaquine hydrochloride (CAMOQUIN HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — amodiaquine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
amodiaquine hydrochloride (CAMOQUIN HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ferriprotoporphyrin IX inhibitor
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amodiaquine hydrochloride?
amodiaquine hydrochloride (CAMOQUIN HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amodiaquine hydrochloride?
CAMOQUIN HYDROCHLORIDE is a marketed brand name for amodiaquine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amodiaquine hydrochloride?
amodiaquine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.